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Abstract
Objective—Uncertainty exists when relying on office (clinic) blood pressure (BP) measurements 
to diagnose hypertension. Home BP monitoring and ambulatory BP monitoring (ABPM) provide 
measurements that are more strongly associated with cardiovascular disease. The degree to which 
patients exhibit uncertainty about office BP measurements is unknown, as is whether they would 
have less uncertainty about other BP measurement methods. We therefore assessed people's 
confidence in methods of BP measurement, comparing perceptions about office BP, home BP, and 
ABPM techniques.
Methods—We surveyed adults 30 years and older (n=193) who all had office BP measurements, 
two sessions of 24-hour ABPM, and two 5-day periods of home BP monitoring. Respondents were 
asked to indicate their level of confidence on a 1 to 9 scale that BP measurements represented their 
“usual” BP.
Results—Respondents had least confidence that assessments of BP made by office 
measurements (median 6) represented usual BP and greater confidence that assessments made by 
home BP (median 7, P<0.0001 vs office) and ABPM (median 8, P<0.0001 vs office) did so. 
Confidence levels did not vary significantly by BP levels, age, sex, race, or education level.
Conclusion—The finding that patients do not place a great deal of confidence in office BP 
measurements, but place a higher degree of confidence in home BP and ambulatory BP 
assessment methods, may be helpful in guiding strategies to diagnose hypertension and improve 
antihypertensive medication adherence.
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Introduction
Controlling hypertension is the single most effective clinical service for reducing overall 
mortality [1]. Unfortunately, only half of people with hypertension have their blood pressure 
(BP) controlled [2]. Among the modifiable factors known to be associated with poor BP 
control, suboptimal therapy plays a substantial role [3,4]. Suboptimal therapy is often due to 
clinical inertia—the failure of clinicians to initiate or intensify antihypertensive therapy 
despite elevated BP levels. One of the factors that plays a role in clinical inertia is clinical 
uncertainty [5]. Clinical uncertainty reflects in part that clinicians appreciate that a clinic 
(office) BP can be a poor gauge of a patient's true BP status, e.g., due to inherent variability 
or white-coat effect [6]. Indeed, ambulatory BP monitoring has demonstrated this to be the 
case [7-9].
It is likely that patients also have some uncertainty about clinic BP measurements. It is not 
uncommon for patients to use home BP monitors or monitors stationed in pharmacies to 
check their BP, and such measurements may vary markedly from clinic BP measurements 
[10-11]. Patients may also realize the hurried manner in which a clinic BP might be taken, or 
may have experienced the lower BP noted when it was repeated later in the same clinic visit. 
A patient's lack of confidence in the BP measurement upon which clinical decisions are 
made may translate into failure to believe that medications are needed, which in turn may 
lead to patients not initiating or persisting with medications.
To our knowledge, no prior research has sought to systematically examine the confidence 
people place in BP measurements or whether patients' confidence in measurements of their 
BP varies by method of assessment. We therefore developed an instrument that can be used 
to assess people's confidence in methods of BP measurement. Specifically, our goal was to 




We created a draft instrument based on a previously validated credibility and expectancy 
questionnaire [12]. We tailored the items for purposes of assessing respondents' beliefs 
about types of blood pressure measurements, creating versions that mirrored each other for 
office BP, home BP monitoring, and ambulatory BP monitoring.
Focus Group
After the initial instrument was created, we held a focus group with 8 people who had 
previously participated in a research study in which they had several office BP 
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measurements taken and wore a validated 24-hour ambulatory BP monitor on two occasions 
one week apart. They also performed home BP monitoring for 5 consecutive days per week 
over two weeks. Details of this BP measurement study have been published previously [13]. 
During the focus group, we asked participants to complete the questionnaires taking careful 
notes as they read and responded to the questions.
Refinement and Review by Experts
The revised instrument was then reviewed by experts in clinical hypertension, practicing 
clinicians, a biostatistician, and an expert in health communication at our quarterly 
Hypertension Research Program meeting. Based on feedback, we made further revisions to 
some of the items to create our final version (Appendix).
Survey Implementation
We mailed paper versions of the questionnaires consisting of the office BP and ambulatory 
BP monitoring items to 408 adults 30 years and older who previously participated in the BP 
measurement study described above. Approximately 3 months later, we mailed the same 
questionnaires in addition to the home BP monitoring questionnaire items to a random 
sample of 50 people who returned the first set of questionnaires, with a gift card for coffee 
included as a small incentive.
Variables
Our main outcomes of interest were self-reported confidence in methods of BP assessment 
on a scale from 1 (not at all confident) to 9 (very confident). We asked a similar item about 
confidence that the measurements are successful in determining a diagnosis (of 
hypertension), and confidence in need to take medications (or not) based on the 
measurements. We also asked about perceived accuracy comparing office to ambulatory BP 
and expected improvement in BP in response to treatment based on BP measurement 
method. To allow comparisons by patient characteristics, we also included demographic 
items, numeracy level using a previously validated scale [14], and office and ambulatory BP 
levels.
Analysis
We first examined missing item patterns. Next, we produced summary statistics for each 
item. For continuously measured response variables, we took note of minimum and 
maximum values, 25th and 75th percentiles, means, and medians. We examined test-retest 
reliability among a subsample using intraclass correlation coefficient. For categorical 
responses, we noted percent responding in each category.
Because reports of confidence on the 1 to 9 scale were skewed, we report medians for these 
variables and compared any noted differences between methods using Wilcoxon signed-rank 
and any differences across categorical variables using Kruskal-Wallis.
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A total of 193 people returned the initial questionnaire. A total of 43 (out of 50) returned the 
repeat questionnaire containing the HBPM items. The mean age of the 193 total respondents 
was 50 years; 43% were men, and 83% were white (Table 1). Approximately 28% had 
previously been noted to have office hypertension, and 77% had ambulatory hypertension. 
The non-respondents tended to be younger and have lower education and lower numeracy 
level. The characteristics of the subset of respondents who returned the repeat questionnaire 
containing the HBPM items are shown in Supplemental Table 1. The subset had a higher 
proportion of men, whites, and presence of office hypertension.
Missing Items, Response Distributions and Outliers
Most items had no missing responses. The ABPM items had from one to three missing 
items, with one respondent missing all of the items. That respondent did, however, complete 
the office BP items, which had no missing responses. As mentioned above, the responses for 
most items (Supplemental Table 2) were skewed. The interquartile ranges for office BP 
items were much wider than those for ABPM or home BP measurements. The medians and 
means for ABPM and home BP measurement items were higher than those for office BP 
measurement items.
Test-Retest Reliability
Among the subsample (N=43), the test-retest reliability of the office and ABPM sets of 
items was high as evidenced by their intraclass correlation coefficients ranging from 0.72 to 
0.88 (Supplemental Table 3).
Confidence in Blood Pressure Assessment Methods
As shown in Figure 1, respondents had least confidence that assessments of BP made by 
office measurements represented usual BP and greatest confidence that assessments made by 
ABPM did so (median 8 vs 6; P<0.0001). A similar pattern was seen for confidence that 
measurements were successful in determining diagnosis. For both of those confidence 
assessments, home BP assessments received a greater vote of confidence than did office 
assessments (median 7 vs 6: P<0.0001), but did not fare as well as ABPM. For confidence in 
needing to take medicine based on measurements, home BP monitoring slightly edged out 
ABPM (median 8 vs 7), but the difference was not statistically significant (P=0.43).
Confidence levels did not vary significantly by age, sex, race, or education level (Table 2). 
Those with lower numeracy level were more likely to place higher confidence in office BP 
(median 7 vs 5; P=0.0001). Even when a discrepancy existed such that office BP was not 
elevated but ambulatory BP average was elevated (i.e. masked hypertension), confidence 
was not affected.
Overall perceptions of comparative accuracy between office and ambulatory BP are shown 
in Table 3. Most respondents (60%) believed ambulatory BP to be a lot more accurate than 
office BP. Approximately 8% indicated neither is accurate.
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Likelihood of Taking Medication and Expected Improvement
Most respondents indicated that they would expect at least some improvement in their BP if 
they were to take medication based on any of the methods of measurement (Table 4). 
However, they indicated a greater expectancy of significant improvement and likelihood of 
actually taking medications in the case of elevated BP if assessed by home or ambulatory 
monitoring. On the scale from 1 to 9, the median reported likelihood was 6 for office BP vs 
8 for both home and ambulatory BP (data not shown).
The majority of respondents (78%) indicated they would be more willing to take BP-
lowering medication if high office BP was confirmed by ABPM (Table 5). Slightly more 
than half (52%) indicated definite willingness to take medication even if office BP was not 
elevated but ambulatory BP average was elevated
Discussion
We sought to compare patients' confidence in three main methods of BP assessment. 
Importantly, we found that patients place greater confidence in assessments of their BP 
status made by ambulatory and home BP monitoring as opposed to office BP measurements. 
This information is useful because home and ambulatory BP measurements have been 
shown to predict cardiovascular events better than office BP measurements [9]. Thus, 
patients seem to place greater confidence in methods that actually are more valid 
assessments of their BP in relation to prognosis.
Office BP measurements are fraught with potential error. Proper technique for measurement 
of BP is often not followed, or measurements are taken in a hurry in an effort to be efficient 
in busy clinical practices [15]. Ambulatory BP monitoring is now considered the reference 
standard for diagnosing hypertension [8,9]. Both the NICE guidelines (UK), and more 
recently the United States Preventive Services Task Force (USPSTF), recommend ABPM to 
confirm the diagnosis of hypertension, with substitution of home BP monitoring if 
ambulatory monitoring is not available [16,17]. Our findings suggest that a potential added 
benefit of this strategy will be that patients will be more confident of the diagnosis of 
hypertension.
In addition to being more confident in ambulatory BP and home BP assessments, 
respondents also indicated greater confidence in the need to take medication based on the 
measurements. This confidence may translate into better medication adherence. A small, but 
not insignificant, proportion of respondents appeared to lack confidence in both office and 
ambulatory BP measurements, and would not take medication regardless of how elevated 
BP was detected. This “no confidence” group did not differ from the remaining respondents 
by age, sex, race, office BP level or ambulatory BP level. They did have lower numeracy 
level, however (data not shown).
We also noted that overall, respondents with lower numeracy level were more likely to place 
higher confidence in office BP. This finding suggests that the value of multiple 
measurements (as obtained with ambulatory or home BP monitoring) and their use in 
providing a BP average may need to be more greatly emphasized to some patients. Future 
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research could also compare the effectiveness of various methods of depicting ambulatory 
and home BP results, e.g., in tabular versus graphical form.
One other learning point that is important not to overlook is that respondents indicated 
greater confidence in ambulatory BP even when office BP was not elevated. More than half 
indicated willingness to take BP medications if ambulatory BP was elevated even if office 
BP was not elevated. Such “masked hypertension” is associated with target organ damage 
and cardiovascular events [18]. While it is not yet known whether treatment of masked 
hypertension improves cardiovascular outcomes, our finding that patients would be willing 
to consider medications based solely on ABPM is a valuable one.
Limitations
This study is the first we know of that examines people's confidence in BP assessment 
methods. However, we acknowledge several limitations. First, our sample was not 
necessarily representative of a general population of clinic patients. Our respondents were 
basing their experience with ABPM on a research protocol, which may be different than an 
actual clinical experience. Importantly, though, the processes were all standardized such that 
approaches to BP monitoring were the same for all respondents. The study participants also 
had a high prevalence of ambulatory hypertension, as described previously [13]. However, 
we would have expected this finding to bias responses less in favor of ABPM. Thus, in a 
more representative sample (e.g., with a higher prevalence of white-coat hypertension), 
ratings may actually be more strongly in favor of ABPM. Another limitation is that we only 
collected data on home BP comparisons from a subsample of the respondents. Finally, we 
did not examine actual medication initiation or adherence.
Conclusion
Both clinician and patient must believe that whatever measurements they are relying on to 
manage BP are an accurate reflection of the patient's usual BP. We found that patients do 
not place a great deal of confidence in office BP measurements, but place a much higher 
degree of confidence in home BP and ambulatory BP assessment methods. Future research 
in more generally representative samples should be conducted and should examine whether 
this greater confidence is associated with better medication adherence.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Confidence in Blood Pressure Measurement Methods
P<0.0001 for all comparisons of office vs home and office vs ambulatory. Difference 
between home and ambulatory were not significant. Bars show interquartile range. For 
example, the median value for confidence that measurements represent usual BP by office 
measurements was 6, with the 25th percentile at 3 and the 75th percentile at 7.
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Table 1
Characteristics of Total Sample Comparing Respondents to Nonrespondents
Respondents (N=193) Nonrespondents (N=215) P-value
Age, mean (SD) 50 (12) 46 (11) 0.0002
Age group (%) 0.002
 30-44 years 37.4 51.7
 45-64 years 46.8 42.0
 65 years and older 15.8 6.3
Male sex (%) 42.5 46.0 0.54
Race (%) 0.004
 White 82.9 67.4
 Black 14.5 27.4
 Other 2.6 5.1
Education level (%) 0.003
 College graduate 81.9 66.0
 Some college 14.0 24.2
 < High school 4.1 9.8
Numeracy level (%) 0.001
 Low/marginal 22.3 38.1
 Adequate 77.7 61.9
Study visit office BP average, mm Hg (SD) 130/80 (12/9) 130/82 (12/8) 0.34
24-hour ambulatory BP average, mm Hg (SD) 137/81 (13/9) 138/82 (12/8) 0.83
Office hypertension (%) 28.4 26.6 0.70
Ambulatory hypertension (%) 76.8 77.6 0.85
Masked hypertension (%) 48.5 53.3 0.33
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Table 3
Perception of Comparative Accuracy between Office BP and Ambulatory BP Monitoring
Percent (N=193)
ABPM a lot more accurate 60%
ABPM a little more accurate 27%
Office a little more accurate 2%
Office a lot more accurate 3%
Neither is accurate 8%
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Table 4
Reported Expectancy of Blood Pressure to Respond to Treatment Based on Measurement 
Method
None or very little improvement (%) Some improvement (%) Significant improvement (%)
Office 14* 43* 43*
Home 5 26† 70‡
ABPM 4 31‡ 65
Percents may not add to 100 because of rounding
*
P<0.002 compared to ABPM
†
P<0.05 compared to office
‡
P<0.005 compared to office
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Table 5
Willingness to Take Blood Pressure-Lowering Medication (%)
Willingness based on office BP in relation to ABPM
 More willing if high BP confirmed by ABPM 78.2
 Not more willing even if high BP confirmed by ABPM 15.0
 Would not take medication either way 6.7
Willingness to take BP-lowering medication if hypertension detected only by ABPM
 Would definitely take medication 51.6
 Would be more likely if office BP was also elevated 37.4
 Would not take medication either way 11.0
ABPM, ambulatory blood pressure monitoring
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